Our people are our greatest asset. When we are connected by a clear purpose and empowered to contribute, progress follows. In this chapter of #InsideHelsinnCulture, Enrico Baroni, Chief of Staff, shares his perspective on Connecting People, Purpose & Progress: how clarity, dialogue, and trust, together with risk awareness, responsibility, and integrity, guide our decisions so that our work delivers meaningful impact and sustainable value for patients. #Helsinn50 #Leadership

This video highlights the real impact of CINV and why prevention matters from the start.  The voiceover is provided by Eva Schumacher-Wulf, who sadly passed away earlier this year. This video honors her tireless work and legacy.

Meet us at the Pharma Partnering US Summit in Boston! Luis Vieira, our Business Development Lead, will be attending on November 19–20. Will you be there too? Connect with Luis to meet and explore potential opportunities together: pharma-partnering-summit.com… #Helsinn #Partnering #BusinessDevelopment

Another important milestone in supportive cancer care. Following the European Commission approval in February, the oral suspension formulation of netupitant/palonosetron has now received approval from the UK Medicines and Healthcare products Regulatory Agency (MHRA). Learn more in our latest press release: helsinn.com/wp-content/uploa… #Helsinn #SupportiveCare #Innovation

#ESMO26 has officially begun! We are excited to be in Madrid, connecting with healthcare professionals, researchers and partners from across the oncology community. 📍 Visit us at Booth 8056 Your perspective matters. Take part in our survey and join the conversation on nausea and vomiting, particularly in relation to ADCs and other innovative anticancer therapies. The topic is also featured in this year's scientific programme, including ePoster 4020eP from the prospective PRAEGNANT trial. #Oncology #Helsinn #SupportiveCare

It’s less than a month until #BIOEurope! Luis Vieira and Stefano Coco will be in Cologne to discuss partnering opportunities and explore new ways to bring innovative healthcare solutions to patients worldwide. To find out more about Helsinn, visit our website: helsinn.com #Helsinn #Partnering

Day 1 at the EORTC-CLTG 2026 Annual Meeting is coming to a close, and it has already been a great opportunity for scientific exchange and insightful discussions on the latest developments in #CutaneousLymphoma. We look forward to continuing the conversation over the next two days here in Berlin. If you are attending, come and connect with us! #EORTCCLTG2026 #Helsinn

A great first day at CPHI Milan! Today, we connected with a lot of partners and industry peers from around the world, exchanging ideas and exploring new opportunities for collaboration. Thanks everyone who stopped by Booth 7B122. We look forward to even more conversations over the next two days! #CPHIMilan #Helsinn #PharmaNetworking

October is Breast Cancer Awareness Month. At Helsinn, we believe that raising awareness is an important step toward improving the patient experience. See the video below to learn more. #BreastCancerAwarenessMonth #BreastCancerAwareness #Helsinn

The countdown to #ESMO26 has begun. From 23 to 27 October, Helsinn will be joining the global oncology community in Madrid to connect, exchange perspectives and engage in conversations around cancer care and supportive care. 📍 Visit us at Booth 8056 Discover new insights from the prospective PRAEGNANT trial in advanced breast cancer (Poster 4020eP), exploring the real-world burden of ADC-induced nausea and vomiting and its implications for patient care. #Oncology #Helsinn #SupportiveCare

Berlin, here we come! Helsinn will be at the EORTC-CLTG 2026 Annual Meeting from October 8 to 10. We’ll be joining leading experts from around the world to explore the latest advancements in #CutaneousLymphoma. Helsinn is also proud to support a symposium focusing on the role of the MF-CTCL skin ecosystem. Looking forward to insightful discussions, scientific exchange, and connecting with the global community. #EORTCCLTG2026 #Helsinn

Today is #SDGFlagDay! Across our four Helsinn locations, colleagues came together to raise the SDG flag and reaffirm our shared commitment to a more sustainable and inclusive future. As part of the UN Agenda 2030, the Sustainable Development Goals provide a common framework for creating positive impact. At Helsinn, we actively support Goals 3, 4, 6, 7, 9, 10, 11, 13, 16 and 17, focusing our efforts where we believe we can make a meaningful contribution to patients, people, communities and the environment. Learn more about our commitments and progress in our latest Sustainability Report: helsinn.com/wp-content/uploa… #TogetherForTheSDGs #Helsinn #Sustainability

🗣️ "This journey has been based on mutual respect which has helped us build and maintain a strong, trusted relationship for over 20 years" – Jimyung Park, HK inno.N. As we conclude our #VoicesOfPartnership series, Jimyung Park from HK inno.N shares reflections on a collaboration spanning more than two decades, shaped by trust and clear direction. #Partnership #Helsinn #Inno

What looks like a simple skin patch may be something more. For people living with mycosis fungoides (MF-CTCL), reaching the right diagnosis can take time. This #WorldLymphomaAwarenessDay, we're helping shine a light on the challenges patients may face on their diagnostic journey. Watch the video to learn more. #WLAD #CutaneousLymphoma #Helsinn

CPHI Milan is just around the corner! Join us at Booth 7B122 from 6-8 October to meet the Helsinn team and discuss opportunities for collaboration across our areas of expertise. Let's connect in Milan. #CPHIMilan #Helsinn #PharmaNetworking

Meet us at #BIOEurope! From 9 to 11 November, Helsinn will be attending BIO-Europe in Cologne. We look forward to connecting with industry peers, exchanging ideas, and advancing patient care together. Find out more about the event here: informaconnect.com/bioeurope… #Helsinn #Partnering

Delivering value means ensuring that patients can access therapies reliably. In this chapter of #InsideHelsinnCulture, Andrea Pontiggia, Chief Commercial Officer, shares his perspective on Delivering Value to Patients and Partners Worldwide: building trusted partnerships, making responsible access decisions, and translating Helsinn’s excellence into real impact across global markets. 👉 Swipe to read his leadership story. #Helsinn50 #Leadership

🗣️ " This isn’t just a company-to-company partnership. It’s a deep, trusted, team-to-team relationship " – Xin Yue, Fosun. In this sixth episode of #VoicesOfPartnership, Xin Yue and Jing Zhao from Fosun Pharma reflect on the values and day-to-day practices that have helped build this deep and trusted relationship. #Partnership #Helsinn #Fosun

Our 2025 Sustainability Report is now available! At Helsinn, sustainability is an ongoing commitment embedded in our way of doing business. Our latest report highlights how we continue to build on this journey, creating long-term value for patients, people, communities and the environment. Read the full Helsinn Group Sustainability Report here: helsinn.com/wp-content/uploa… #Sustainability #Helsinn #QualityOfLife

As Helsinn celebrates its 50th anniversary, we are proud to share an interview with @RBraglia and Gabriele Braglia in @BusinessFocus_ , reflecting on our journey, the values that continue to guide us, and our ambitions for the future. 👉 Read the full interview: issuu.com/ceomedia/docs/hels…